Researchers are using RNA in a new approach to fight HIV

FEBRUARY 20, 2024byUniversity of WaterlooGraphical abstract. Credit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2023.12.043Society learned about the value of mRNA dur

Updated on: March 30,2024

Researchers are using RNA in a new approach to fight HIV

FEBRUARY 20, 2024byUniversity of WaterlooGraphical abstract. Credit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2023.12.043Society learned about the value of mRNA dur

Updated on:March 30,2024

Protein production glitches in Huntington's disease revealed

by Shafaq Zia,Whitehead Institute for Biomedical ResearchRNAs with expanded CAG repeats (red) form regions of high concentration in the nucleus (blue) of a cell. Credit: Rachel Anderson/ Whitehe

Updated on: March 14,2024

Protein production glitches in Huntington's disease revealed

by Shafaq Zia,Whitehead Institute for Biomedical ResearchRNAs with expanded CAG repeats (red) form regions of high concentration in the nucleus (blue) of a cell. Credit: Rachel Anderson/ Whitehe

Updated on:March 14,2024

The dual role of well-known protein sheds light on Parkinson's disease mechanisms

NOVEMBER 6, 2023by Lisbeth Heilesen,Aarhus UniversityNew research from Aarhus University with international collaborations has revealed that natural aSN activates an important calcium pump in th

Updated on: March 30,2024

The dual role of well-known protein sheds light on Parkinson's disease mechanisms

NOVEMBER 6, 2023by Lisbeth Heilesen,Aarhus UniversityNew research from Aarhus University with international collaborations has revealed that natural aSN activates an important calcium pump in th

Updated on:March 30,2024

Study examines perceptions of benefits and risks of data sharing in dementia research

by Sam Fahmy,Georgia State UniversityCredit: Pixabay/CC0 Public DomainExpectations for data sharing among scientists and returning research results to study subjects have evolved in recent years

Updated on: April 06,2024

Study examines perceptions of benefits and risks of data sharing in dementia research

by Sam Fahmy,Georgia State UniversityCredit: Pixabay/CC0 Public DomainExpectations for data sharing among scientists and returning research results to study subjects have evolved in recent years

Updated on:April 06,2024

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

DECEMBER 14, 2023 Editors' notesby C. Michael White,The ConversationCredit: Pixabay/CC0 Public DomainPrescription drugs and vaccines revolutionized health care, dramatically decreasing death

Updated on: March 14,2024

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

DECEMBER 14, 2023 Editors' notesby C. Michael White,The ConversationCredit: Pixabay/CC0 Public DomainPrescription drugs and vaccines revolutionized health care, dramatically decreasing death

Updated on:March 14,2024

Mechanobiomaterials: A rising field using mechanobiology principles to program functional biomaterials

by Shanghai Jiao Tong University Journal CenterA closed-loop workflow of designing mechanobiomaterials. Credit: All authorsA group has proposed a new concept of mechanobiomaterials, which is inspired

Updated on: July 08,2024

Mechanobiomaterials: A rising field using mechanobiology principles to program functional biomaterials

by Shanghai Jiao Tong University Journal CenterA closed-loop workflow of designing mechanobiomaterials. Credit: All authorsA group has proposed a new concept of mechanobiomaterials, which is inspired

Updated on:July 08,2024

Perfecting 3D-printed blood vessels with pores

JANUARY 17, 2024byPohang University of Science and TechnologyFabrication process of S-SDVs and the results of HUVECs migration through pores. Credit: POSTECHDue to the substantial clinical deman

Updated on: March 25,2024

Perfecting 3D-printed blood vessels with pores

JANUARY 17, 2024byPohang University of Science and TechnologyFabrication process of S-SDVs and the results of HUVECs migration through pores. Credit: POSTECHDue to the substantial clinical deman

Updated on:March 25,2024

Scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers

byDuke-NUS Medical SchoolDuke-NUS scientists show that FBXW7-mutant cancers are resistant to Wnt inhibitors by comparing the impact Wnt inhibitor ETC-159 has on cancer cells with and without FBX

Updated on: April 28,2024

Scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers

byDuke-NUS Medical SchoolDuke-NUS scientists show that FBXW7-mutant cancers are resistant to Wnt inhibitors by comparing the impact Wnt inhibitor ETC-159 has on cancer cells with and without FBX

Updated on:April 28,2024

Key mechanisms identified for regeneration of neurons

byLudwig Maximilian University of MunichCredit: Pixabay/CC0 Public DomainNeurological disorders, such as trauma, stroke, epilepsy, and various neurodegenerative diseases, often lead to the perma

Updated on: July 05,2024

Key mechanisms identified for regeneration of neurons

byLudwig Maximilian University of MunichCredit: Pixabay/CC0 Public DomainNeurological disorders, such as trauma, stroke, epilepsy, and various neurodegenerative diseases, often lead to the perma

Updated on:July 05,2024

Measles cases surge 20%, global study shows

An electron micrograph of the measles virus. Credit: CDC/ Courtesy of Cynthia S. GoldsmithMeasles infections soared by a fifth last year to over 10 million cases globally, revealing alarming gaps in v

Updated on: December 03,2024

Measles cases surge 20%, global study shows

An electron micrograph of the measles virus. Credit: CDC/ Courtesy of Cynthia S. GoldsmithMeasles infections soared by a fifth last year to over 10 million cases globally, revealing alarming gaps in v

Updated on:December 03,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

Mechanical constraints guide spatial pattern of glioblastoma cancer stem cells

by Shanghai Jiao Tong University Journal CenterOne photo from the article titled "Mechanical constraints in tumor guide emergent spatial patterns of glioblastoma cancer stem cells" Credit: N

Updated on: April 06,2024

Mechanical constraints guide spatial pattern of glioblastoma cancer stem cells

by Shanghai Jiao Tong University Journal CenterOne photo from the article titled "Mechanical constraints in tumor guide emergent spatial patterns of glioblastoma cancer stem cells" Credit: N

Updated on:April 06,2024